GlassScriptPhysician profile
Annette C Larson
NPI 1649361445
$1,110.93
in general payments reported to CMS, 2019-2025
20 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $219 · 2022: $212 · 2023: $177 · 2024: $143 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $260.83 | 2021-2025 | Darzalex, Talvey, Carvykti |
| Pfizer INC. | $241.87 | 2024-2025 | |
| Astellas Pharma US INC | $105.77 | 2021-2024 | Xospata, Vyloy |
| Gilead Sciences, INC. | $77.13 | 2021-2024 | Trodelvy |
| Lilly USA, LLC | $66.27 | 2021-2025 | Jaypirca, Verzenio |
| Eisai INC. | $42.78 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $36.87 | 2021 | |
| Puma Biotechnology, INC. | $35.90 | 2021 | |
| Sobi, INC | $34.61 | 2023-2024 | |
| Karyopharm Therapeutics INC. | $33.50 | 2021 | |
| Emd Serono, INC. | $28.24 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $19.68 | 2022 | |
| Amneal Pharmaceuticals LLC | $19.41 | 2023 | Neupogen, Avastin, Neulasta |
| Kyowa Kirin, INC. | $18.19 | 2024 | Poteligeo |
| Ipsen Biopharmaceuticals, INC | $16.39 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acrotech Biopharma INC. | $15.53 | 2022 | |
| Daiichi Sankyo INC. | $15.48 | 2024 | Enhertu |
| Kite Pharma, INC. | $15.08 | 2023 | |
| Rigel Pharmaceuticals, INC. | $14.44 | 2022 | |
| Genentech USA, INC. | $12.96 | 2023 | Columvi, Polivy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Annette Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.